Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by SouthernTierTomon Feb 21, 2021 12:35pm
256 Views
Post# 32621736

Actually the MEDIC Study was 857 patients - "but LOOK"...

Actually the MEDIC Study was 857 patients - "but LOOK"...checkout the investigators!  They include the investor of the MODS organ scoring system, the co-intentor of the EAA, Dr. Phil Dellinger ( our phase 3 Euphrates lead ), the "incomparable" Dr. Jean-Louis and more....

I wonder why these GIANTS in medicine would "stick with" an idea so long and continue to advance it?  And to think...just a couple short years ago, perhaps now our "most important GIANT' questioned the efficacy as it realted to cost at an EU castle ( aka seminar ) with with all the giants in attendance ; - )

Think the childish atention to this bullboard 24 / 7 is "accidental" ---- LOL,  FRAUDS working this bullboard....and for VERY good rea$on ; - )

Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study


<< Previous
Bullboard Posts
Next >>